Raul R. Rodriguez

atRigel Pharmaceuticals· In proxies 2021–2025

Pay in FY2024-13% from the year before · Rigel Pharmaceuticals stock +16.0% the same year

Raul R. Rodriguez was paid $3.0M in FY2024 (Dec), down 13%. Rigel Pharmaceuticals stock rose 16.0% that year.

Pay$100 in the stock at the end of FY20 → $48

Pay is from the Summary Compensation Table of each Rigel Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

RIGL
Rigel PharmaceuticalsPublic company · 5 yr
- 2021 – Present · 5 yrStock in role +38%

Roles come from the proxy statements of each company.

Activity

Pay
Rigel Pharmaceuticals Director pay fell 13% to $3.0M. The stock rose 16% in FY2024 (Dec).
DEF 14AApr 10, 2025
Pay
Rigel Pharmaceuticals Director pay rose 20% to $3.4M. The stock fell 3% in FY2023 (Dec).
DEF 14AApr 10, 2024
Pay
Rigel Pharmaceuticals Director pay fell 16% to $2.9M. The stock fell 43% in FY2022 (Dec).
DEF 14AApr 10, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?